ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001206.1|Indolmycin_1 # 1 # 363 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0001206.1|Indolmycin_1 	1	363	-	Loose	310	24.6386	Type B NfxB	29.27	3004060	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGTCGGGGGGATCTGACTAATCGAGAGTGGTCGCTACTGGAGCCGCATCTGCCTCCGCCGGGTGGTCAGGGCGGCCGGTGGAACGATCACCGCATCGTCATCGACGGGATCATGTTTCGGATTCGGACCGGGGTTCCGTGGCGTGACCTGCCGGAACGCTACGGCTCGTGGAAGACCGTCTATGAACGGCATCGCCGCTGGTCGGCGGACGGCACCTGGGACCGGATCTTGCAGTCGGTCCAGGCCGACGCCAACCTCGCGGGCCGAATCGACTGGTCGATGGTCGGCGTCGACTCGACCTCCTGCCGGGCCCATCAGCACGCGGCCGGCGCCCGCAAGGCCCGGCCGCGGGTCCCGAAA	MGRGDLTNREWSLLEPHLPPPGGQGGRWNDHRIVIDGIMFRIRTGVPWRDLPERYGSWKTVYERHRRWSADGTWDRILQSVQADANLAGRIDWSMVGVDSTSCRAHQHAAGARKARPRVPK	MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGETVLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLEALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHGASNPARS	64.71	gnl|BL_ORD_ID|2342|hsp_num:0	2693			261	384	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0001206.1|Indolmycin_4 # 2494 # 3483 # 1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.601	BGC0001206.1|Indolmycin_4 	2494	3483	+	Loose	700	26.5646	PDC-125	27.06	3006501	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	TTGACCAGGACCGATTTCGCCCAATCCGCGGTCGCATCCATATTCACAGGAGCCATTGCCTCTCACGCTGCCGTACTTGCCGACGACCTTGGCTTGTTTGATGCGCTGGCAAAAGGTAAGCTGCGCAATCGAGACCTTGATCGTTCCCCGTGGCTGCGTAATCGAATACGAATATCGGGCGCGCTTGAGGCTTTGTGTCGAGTGGGAGCCGTACAGCGCTGCACTGACGGCTATGAACTCACCGATGTTGGTACGGAGCTTGCAGGGCAGGTTCCTGTCTTCCGCCTGTGGCTGGGCGGTTACGCATCCGTCTTGGCCGGTCAAATCTCCATCGGCGCTGACCCTGCGACTGGTGTGCACGGCGGAATCGTGGCCGAGTCCTCCGGTGCGATCGGGGCTCGCTATCTCGACGAGACCATCGTCAATCTGCTGGAGTCGCTGCGCCCCGAGGGTCGCATCTGCGACATCGGCTGTGGTACCGGTGCCAGACTCCTGCGCGTCTGTCGCCGGGTGAACCAGCCCGGAATCGGATACGACCTATCCGCCAAAGCGGTTGAAGCGGCCCGGGAAACCGTCGACGAGGCACGTCGGATCGGTGTCGACATTGACGTCCGGCAAGGGGATGCGACCGCTCTCACTCAGGACCACCCCGACGTTGACATCGTCACTCAGGCATTCATGACGCATCACATCGCCCCCGATGAGTACTGCGCGGCTGTGCTGCGTTCCTATCGATCGCGTTTTCCTCGGGCTCGCTATCTCGTCATCTTCGACACGGTGCCGTCACAGGACAGCGAAGAACCGGAAATATTCGCCCCAGGATTCGACTACATACATGCCCTCCAGAACATGGAACCGCGGAGCAGAGGTGCGGCTCGGAGAATGTTTACCGAAGCCGGATATATCTGCCGGGAGGAGGTTGAGCTGGCTGTTCCCAACAGCTATGCATGGGTTCTTGAAATGCGTGACCGCGAGGGGCCGGCTTCATGA	MTRTDFAQSAVASIFTGAIASHAAVLADDLGLFDALAKGKLRNRDLDRSPWLRNRIRISGALEALCRVGAVQRCTDGYELTDVGTELAGQVPVFRLWLGGYASVLAGQISIGADPATGVHGGIVAESSGAIGARYLDETIVNLLESLRPEGRICDIGCGTGARLLRVCRRVNQPGIGYDLSAKAVEAARETVDEARRIGVDIDVRQGDATALTQDHPDVDIVTQAFMTHHIAPDEYCAAVLRSYRSRFPRARYLVIFDTVPSQDSEEPEIFAPGFDYIHALQNMEPRSRGAARRMFTEAGYICREEVELAVPNSYAWVLEMRDREGPAS	MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITLKGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWPALQGSRFDGISLLDLGTYTAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNPSIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDRPLRVGPGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEAYDWPIDLRRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRDVGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR	82.87	gnl|BL_ORD_ID|4191|hsp_num:0	5261			381	627	
BGC0001206.1|Indolmycin_5 # 3480 # 5192 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.647	BGC0001206.1|Indolmycin_5 	3480	5192	+	Loose	750	26.9498	bmr	30.51	3003007	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; nucleoside antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGCTGGACGACAAGAGAATTCTCATCATCGGCGCCGGCGAAGTGGGAACTGCTGTTGCCGAGGATCTGGTGAACAGATCCGATCCGACCGAGATCATTATTCACACGTCACGTCAGCAGACAATGGACATGAGAGTCGGCCACCTAAAGGAGATGGCTGGCCCTCGAACGCTGCTGACCGGGTCGTGGGGAGACATTTTCGCGCCGTACGAGCTCACCCACAGGTCTCGTTCGGAGATCAATGACCGGAACGTAAGACTGGCGCTGGCGGAATTCTTTCTGCAGCCGTCCGGAGAGGCTCAGTTGCGGCGGACAACCATCTACGAGCTGATCAGTCGCCATCGCCCGCACATCGTCATCGACGCCGTCAACTCCGCCTCCGTATGCACCTACACCGAGGACCCGCACCAGACATGCGGGGAACTGCTCGATCTCGCCCGAGGAACGGGCGGCCCTCGGACTGCCGAAGCGCCGGCGGAACTACCCGCGGTGACGCCCGACATCGCCGATGTGGCGACCGATGCGTTGTTGTCCCTCTCCACCCCGATCCTTCACCGCTACGTCGACTCGCTGCGCCGGGCCATGGCGGACTTTCAGGTGGAACGATTCATCAAGGTGTCGACGACCGGGCTGGGCGGCATGGGCTACAACTGCCCCTACACCCACGGCTCTGTCACCGAGTTCGGACTGTCCGACGCTCTGGTGGGGAAGATCGGCTCCGCCGGCGTGCTCCACCAGCTGCTGTGGAACCTGCATCATACTGCGGGGTGCGATGTCCGCCTGGTGATCCCCGCTGCGCTGATCGGCTGGGAGTCCGTGCGTCACGGCGCGTACACCTCACGCGGACGGCCGGTGGCACTGCAGGACTGTTCCCGTCCCCTGCCGCTGCACCTGGACCGGCCGCTGGGCGAACACGCAGCGGCGTCATCGGTGGCGGAGCCCGCCGCCGAGGACGAGCCGTCGGCGGAGATGGTCCATGTGCCGGCCGGTGACAATTCCACCTACAGCCGGGCGGAGATGAGTCTGAGCACGGCGCTTGGCCAGTTCGAAAGCGTGACACGTGAAGAAGTCGCCGCGGCAGTGCTGGACACACTCCTCGGCTCCACCCGCTTCGATCTCTTCACGGCCATGGACACCGCGTCATTGCAGTCCTCCTATCTGGCAGCCCAGATGCGCACCTCCACACTCACGTCCATGAGGCAGCTGGAGAAGGCGTACGACCGACCGAGCATCGTCAGCGGGAACCTCGGGCCCACGATCTCCAAGGACCTGCTGGAACTGCATGTCCTGTGCACGGCGGCTGGTTCCTTGGAGCAGGCGCGCACCATGAGCACCACCGTCCTCGCCTCAAGCGCCTCGGCTCTCGTCCGCGAGGACGTGTATCTGCGGCAGCAGGCACTCTCCATCGGCCTGGCCGTGCTACTGCCCGACGATCAGTGGCTGGCCGGACCACGCCTTTCGGTGCCGAGCCGGATCGACCCCGAGGCCAAGGTTACCCGCGCCGACATCGACGACTGGTCACGCCAGGGATGGGTGGATCTGCGACCGGCCAGGATCCTGCACTGGCAGGAGAACCTCCGGCGGATCGAACAGGACGCATCTGCCGGGAAGACCGCGTTCGCGCTCGACGACACGGCGTACGACGTCGGAGAAGTACTCGCCTACCACTACAAGCTCACCGGACAGGCCCGTCGCATCAAGGGCCTGTGA	MKLDDKRILIIGAGEVGTAVAEDLVNRSDPTEIIIHTSRQQTMDMRVGHLKEMAGPRTLLTGSWGDIFAPYELTHRSRSEINDRNVRLALAEFFLQPSGEAQLRRTTIYELISRHRPHIVIDAVNSASVCTYTEDPHQTCGELLDLARGTGGPRTAEAPAELPAVTPDIADVATDALLSLSTPILHRYVDSLRRAMADFQVERFIKVSTTGLGGMGYNCPYTHGSVTEFGLSDALVGKIGSAGVLHQLLWNLHHTAGCDVRLVIPAALIGWESVRHGAYTSRGRPVALQDCSRPLPLHLDRPLGEHAAASSVAEPAAEDEPSAEMVHVPAGDNSTYSRAEMSLSTALGQFESVTREEVAAAVLDTLLGSTRFDLFTAMDTASLQSSYLAAQMRTSTLTSMRQLEKAYDRPSIVSGNLGPTISKDLLELHVLCTAAGSLEQARTMSTTVLASSASALVREDVYLRQQALSIGLAVLLPDDQWLAGPRLSVPSRIDPEAKVTRADIDDWSRQGWVDLRPARILHWQENLRRIEQDASAGKTAFALDDTAYDVGEVLAYHYKLTGQARRIKGL	MEKKNITLTILLTNLFIAFLGIGLVIPVTPTIMNELHLSGTAVGYMVACFAITQLIVSPIAGRWVDRFGRKIMIVIGLLFFSVSEFLFGIGKTVEMLFISRMLGGISAPFIMPGVTAFIADITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEVHSRLPFFFAAAFALLAAILSILTLREPERNPENQEIKGQKTGFKRIFAPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTASDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLLTTVHSYVAILLVTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMLFDIDVNYPFYFATVTLAIGIALTIAWKAPAHLKAST	146.53	gnl|BL_ORD_ID|1152|hsp_num:0	1256			207	372	acriflavine; puromycin; chloramphenicol
BGC0001206.1|Indolmycin_7 # 6595 # 7755 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.633	BGC0001206.1|Indolmycin_7 	6595	7755	+	Loose	460	28.8758	OXA-296	32.14	3001751	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCAGAAAATGGAACGGTTCAACAATCTGACGCGCTACGAGCATGTCGGAATCAATCAGGCCATCAATCTCGCCGATGGCCACGCCCATCAGGGCCAGAACAGCACACAACAGGCCATCGTCGCCGACCTGCCGAACATCTTCGAGGCGGCCGAGAACGCTCTGCAGGCCACCACGGAGCGGGAGTTCCAGCGGGCCTTCTACACCCTGGCAGGACAGCACTCCGCGGTCGACCACCCGCGCACCATGCTGTGCTACTCGGCGTCCCTCTCCACCGACCTCGTGGCCACCTTCCTGGCGAGCCGAAACCTGACGGTGGGTCTGCTGCAGCCGTGTTTCGATAATCTGGCGACCATCCTGCGCCGGAGGCAGGTGAAGGTCGTACCTCTGGGCGAGGAACAGTTCCGTCCCGAATCACTTGACCGGACGTTCGCCGAGTTGAACACGGACGCGGTGTTTCTCACCCTGCCCAACAACCCGACCGGCTTCCACCTGGACCAGGAGCAGTTCCGCCGTGTCATCGACCTCTGCGCCGAGCACCAGAAGATACTCATCGTCGACTGCACCTTCCGATTCTTCGCGCCGACACCGTTCTGGGACCAGTACGCGCAGCTGGAGGAGTCCGGCATCAGCTACGTCGTGGTCGAGGACACCGGGAAGACCTGGCCGACCCAGGACCTGAAGTGCAGCATCCTCGCCGTCAGCACCGACCTGCACGAGTCGGTCCTTGAACTGCACAACGACATTCTGCTCAACGTCAGTCCGTTCATCCTGCAGTTGCTCACGGCTTATCTCCGTGACACGGAGCGAAATGGTCTGCAGCAGACCATCTGGAGTGTCGTACGGGCCAACCGCATTAGCCTGCGCAAGGCCCTGGAAGGGACCGTCCTCGTTCCCGCGCACCCGGAGAGCACCATCAGCGTCGAATGGGTGCGCATCGACCATCCGTCGCTGCGCAGCGACGACCTGGTGGAGATGCTGGCGAAGTCCCAGGTGGGCATCCTTCCCGGCGACCACTTCTATTGGGACGACCACGAGACGGGGTCACACTTCATCCGCTTCGCCCTGGCCCGCGAGGAACGCTGGTTCGCGACGGCCTGCGGTAGCCTGCGGGAGGCCCTGCTGGCCCGGCCCGAGCTCATCGAGGGCGCCGGTTCATGA	MQKMERFNNLTRYEHVGINQAINLADGHAHQGQNSTQQAIVADLPNIFEAAENALQATTEREFQRAFYTLAGQHSAVDHPRTMLCYSASLSTDLVATFLASRNLTVGLLQPCFDNLATILRRRQVKVVPLGEEQFRPESLDRTFAELNTDAVFLTLPNNPTGFHLDQEQFRRVIDLCAEHQKILIVDCTFRFFAPTPFWDQYAQLEESGISYVVVEDTGKTWPTQDLKCSILAVSTDLHESVLELHNDILLNVSPFILQLLTAYLRDTERNGLQQTIWSVVRANRISLRKALEGTVLVPAHPESTISVEWVRIDHPSLRSDDLVEMLAKSQVGILPGDHFYWDDHETGSHFIRFALAREERWFATACGSLREALLARPELIEGAGS	MQQRLFYFGCLLLLTQLSACHMNRAQTSNQSVQKAVLQAPSERPEEIKQLFNSAHTSAVFITYDGRQFNRYGNALARAQNAYIPASTFKILNALIGLQHHKVSTSEVFKWKGEKRSFPAWEKDMNLAQAMQLSAVPVYQQLARRIGLELMQKEISRLGFGNQKIGQQVDNFWLVGPLKITPEQEAQFVYQLATEQLPFDVKVQKQVKEMLYIERRGDTKLYAKSGWGMDVKPQVGWYTGWVEQANGQITAFVLNLEMHDGDDVGERKQLTLDALDKLGLFFYLH	135.92	gnl|BL_ORD_ID|2210|hsp_num:0	3356			126	267	cloxacillin; oxacillin; cefalotin
BGC0001206.1|Indolmycin_8 # 7752 # 8711 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.689	BGC0001206.1|Indolmycin_8 	7752	8711	+	Loose	200	99.7525	vanH gene in vanA cluster	28.31	3002942	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAGCGCCACAAGAACTCCGCGCATAGTATGTCTCGACGAACCGACCTATCTGACCGGGGGTTTCCTGCGACAGCTGTCCGCCCTGGGCGCGGTACGGGTGCACTACGACCGCCCCGGCCAGCGGGAGGCCGTGCGCAGGCTCGCGACAGCCGATGTGGCACTCGTCGAGTGGACCCGGCTGTCCGCGGACCTGCTGCGAGCGGTACGGGACACGGCCGGATCAGGAGGCGTTCGGCACATCTCCACCCTGCTCTCGGCCACGGACCAGATCGATCTGGGCGCCACCCGTGAACTCGGTATCAGCGTGTCGCACTGCCCGGACTACTCGGTGTCCGCCGTGGCCGAGTACGTCATCGCGTGCGTCGGAACACTGAGCCGCCAGATCCTTCCGGCGAGCCGGGCCGGCGCCGCCGGGGTGGCTCACCGCTATCCGCCCTTCCTGGGCGGGGACCTCCGCGGTTCGGTGCTCGGCCTCGTCGGTACGGGCAGGATCGGCAGGGCGGTCGCGCGCCGGGCCGATGCCCTGGGCATGCGCGTGCTGGGAAGCAACCGGGAAGGACGCGCGGTACCCGGTGTCGAGGTCGTGGGCCTGGAGGAACTGGCGCGACGCAGCGATGTGCTGTCCGTGCAAGTGCCGTCCAACGAGAGCACCCGTGAGCTGCTCAGCGAGGAACTCATCGGTCTGCTCAGGCCGGGCTGCGTGGTCGTGAGCGTCTCCCGTGCGCAGACCTTCGCCATGCACGCCCTGGCGGACCGGCACCGGGCGGGCGAACTCGGCGGCATCGCTCTGGATGATGCCCCGGCGGAGCTCGTACCCACGCTCTCGGCTCAGCCCAACACCCTGCTCACGCCTGGGATCGCGTGGTACAGCCGGGATTCGCGCCAGGACAACCTAACCGAAGTCCTGGCGAATGTGAGCGGCTTCCTGAAGGGGGAACCGGTCAATGTCGTTCGATAA	MSATRTPRIVCLDEPTYLTGGFLRQLSALGAVRVHYDRPGQREAVRRLATADVALVEWTRLSADLLRAVRDTAGSGGVRHISTLLSATDQIDLGATRELGISVSHCPDYSVSAVAEYVIACVGTLSRQILPASRAGAAGVAHRYPPFLGGDLRGSVLGLVGTGRIGRAVARRADALGMRVLGSNREGRAVPGVEVVGLEELARRSDVLSVQVPSNESTRELLSEELIGLLRPGCVVVSVSRAQTFAMHALADRHRAGELGGIALDDAPAELVPTLSAQPNTLLTPGIAWYSRDSRQDNLTEVLANVSGFLKGEPVNVVR	MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEISASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVRNVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRSIEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYELVKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQALRDTVEKTIKNCLDFERRQEHE	99.07	gnl|BL_ORD_ID|4669|hsp_num:0	178			168	945	vancomycin; teicoplanin
BGC0001206.1|Indolmycin_9 # 8698 # 9387 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.706	BGC0001206.1|Indolmycin_9 	8698	9387	+	Loose	400	25.409	ArnT	40.0	3005053	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGTCGTTCGATAACCAGAACAGGGACAAGACCCCGGTCGGCGCCTTCCCCTGGCTGGAGGACCAGCTCAGCCACACCGGCGCTGCCGCCGTGGTGAGACGGACACCGGGGATGCCGAATGCCCTTGAGGTCCGGGTGCACGCCGATCGGGCTCCGGAGATCTGCGTGCTGTGCTGCTGGCACGAGCCGTGGACCGCCGGACCTCTTGGGATCGAGTCCGACGTCTCCATGTCCGCGCTGTACGTGCTGGAACTGCTCGACCACGCCTGCCGCGCCGCCGGACCGTCCCTCGTGGCGCACTTCATCGCCGACGACAACGAGCACTCGCGCACCTCTGCCTTCGCGGCCGGCCGCGCTCAGCTGGCGGAAGCGCCCGCACCCGTACTTGCCGTCGTCGCGGCGGGTTGTGCGCCGGGGGGCGGGCTCGCCGTTCCCTCGACCGCGGGGACAAGGCAGCCGCTGACCGTACCGCCGGCCCTGCCCCGGCTGACCGAAGGCCTCGACCCCGATGTGATCGAGGCACTGGAAGTCTGTGCCGAGGCCGGGATCACGGCCTGTGTCGTGGATCCCGCCGGCCGCGATCACGATCTGTGGCCGGCCACCGAACTGTACCGGACGCTGGCCGCCGCGGCCCGCGGAGAGGAGTGGAACCCGCATGCACACGGACTGGGAGACATCGGAGTCGGCTGA	MSFDNQNRDKTPVGAFPWLEDQLSHTGAAAVVRRTPGMPNALEVRVHADRAPEICVLCCWHEPWTAGPLGIESDVSMSALYVLELLDHACRAAGPSLVAHFIADDNEHSRTSAFAAGRAQLAEAPAPVLAVVAAGCAPGGGLAVPSTAGTRQPLTVPPALPRLTEGLDPDVIEALEVCAEAGITACVVDPAGRDHDLWPATELYRTLAAAARGEEWNPHAHGLGDIGVG	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	41.56	gnl|BL_ORD_ID|2783|hsp_num:0	3795			1074	1179	colistin A; colistin B
BGC0001206.1|Indolmycin_10 # 9353 # 10066 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.657	BGC0001206.1|Indolmycin_10 	9353	10066	+	Loose	550	37.3502	RlmA(II)	31.58	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGCACACGGACTGGGAGACATCGGAGTCGGCTGAGGACTACTCCAGAAACACCGCGGCGGCACAGTGGGAACCCATGGGATATCCCGCGGTGTTCCGCAGCCTCGCGCTCGCCACGACGGACTCGGACAACGCCCCGCCCATCCTGGACTACGGATGCGGACCGGGCTTCGTGGACCGGCATGTCGCGGAGAAGTACGGCCGCAGGGTCATTGCCGTCGACATCTCGTCGTCGATGATCGATCTCGCCCGGTCCCAGCACTCTCACCCGCTCGTCACCTATCGGCATGTGCCCGACTCGCAGCTGGACTTCCTGGGCGACAAGGAAATCGGCGGCTGCATGAGCTGCTTCGTACTCATGCAGATGGCGGACAGCGACACCCAGGTCGAGATCTGCCGCCGGATCAGGAGAACCCTCGCCCCCGGAGCGATGCTCGCGGTACTCAACACACACCCGGACAGCGTGGGCATCCAGTTCGCCACCCTCCGCAACGGGGAGCCGGATCGGGTCTATCAACCCGGCGACCCGATGACCACCGTCCTCACCACGGACAAGGGCGTACTGCGCCTACAGGACTACTACTGGCGCGTCACGGACTACGTTCATGCCCTGGAAGCCGCGGGCTTCCACGAGGTCACGGTCGAGCACCTGCCACCGCCACCGGCAGACCCGACGCCCCACCCGCAGTTCCTCCTGGTGCGCGGAACAGCCTGA	MHTDWETSESAEDYSRNTAAAQWEPMGYPAVFRSLALATTDSDNAPPILDYGCGPGFVDRHVAEKYGRRVIAVDISSSMIDLARSQHSHPLVTYRHVPDSQLDFLGDKEIGGCMSCFVLMQMADSDTQVEICRRIRRTLAPGAMLAVLNTHPDSVGIQFATLRNGEPDRVYQPGDPMTTVLTTDKGVLRLQDYYWRVTDYVHALEAAGFHEVTVEHLPPPPADPTPHPQFLLVRGTA	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	84.04	gnl|BL_ORD_ID|2052|hsp_num:0	2274			234	405	tylosin; mycinamicin
BGC0001206.1|Indolmycin_11 # 10122 # 11207 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.665	BGC0001206.1|Indolmycin_11 	10122	11207	+	Loose	350	25.0238	mfpA	40.0	3003035	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGTCATCGACACCCGCCCCCGGCTTCGGGAGAATTGCCGAAATTGACCGCCTCTCCGCCTATCGACAAGAGGACGCGGCGGCAGAGGGCGAGGACCGGTTCGTATGGGACCTGTCGAACAACGAATCCGCCCTGCCCCCGTTGCCCGCAGTGGCGGAGGCGGTGCGACAGGGAGGCTTGCACACCGCTCGGTACCCGGACCCCACCGCCGGCTCATTGGTACGGGCGCTCTCCCGGCACTTCGGCATCGACACGCGGAAGGTGCTGGTCGGCCCCGGTAGTGCCGGTGTGCTCCAGCAGCTCCTGCTCTCCCTGTGCGGTGATGGTGACGAGGTAATCCACGCCTCGCCGTGTTTCGACGCCTACCCCCTGCTGATCGCCGTTGCGGGGGCGAGGTGCCTGCCGGTGCCTCTCACTGAACTCGGAGACCATGATCTGCCGGAGATTTTGGCCAGAGTGACCCCCCGCACGCGAGTCGTCATACTGTGCTCCCCGCACAACCCCACGGGGAGCCGCCTGCCGGACACCGATCTGCGCGGATTCCTCGCAGATCTTCCCCGGCACGTGACCGTCGTTCTCGACGAGGCCTACATCGAATTCGACGAGGCGAAGGAGCCACGTGACCTCAATGTTCTCCGCCGGGACCCCAGGGTCGTACTCCTGAGAACCTTCTCCAAGGCGTACGGGCTGGCGGGACTGCGAGTCGGCTACGCGCTCGCTGCGCCAGACATCCTGGAACGTGCTCGCAAGACCGCCATTCCCTTCTCTGTCACTCGCACCGCCGAGCTCGCTGCGATCGTCTCGCTGGAGCAACAGGAGGCACTCGCCGAACGGATGGCGCACACGAGGAAACTGCGCACCGATCTGCACGCGGCCCTCGACGCCGAAGGGCTCTCGCCCCTGCCCTCGTGCGGAAACTTCATCTGGATCCCGCTCGGGAGTTCCTCGGAGAGCTTCGCCGCCATGGTGCAGGGCGCGGGGATCAAGGTGAGGGCCTGTCCGGGGCAGGGCGTGCGGATTTCGGTGGGAAGCGAGCCTGCCCACCGGCACCTGCTTGAAGTGGTACGGCACCGGGCCAAGAGCTGA	MSSTPAPGFGRIAEIDRLSAYRQEDAAAEGEDRFVWDLSNNESALPPLPAVAEAVRQGGLHTARYPDPTAGSLVRALSRHFGIDTRKVLVGPGSAGVLQQLLLSLCGDGDEVIHASPCFDAYPLLIAVAGARCLPVPLTELGDHDLPEILARVTPRTRVVILCSPHNPTGSRLPDTDLRGFLADLPRHVTVVLDEAYIEFDEAKEPRDLNVLRRDPRVVLLRTFSKAYGLAGLRVGYALAAPDILERARKTAIPFSVTRTAELAAIVSLEQQEALAERMAHTRKLRTDLHAALDAEGLSPLPSCGNFIWIPLGSSSESFAAMVQGAGIKVRACPGQGVRISVGSEPAHRHLLEVVRHRAKS	MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG	197.27	gnl|BL_ORD_ID|734|hsp_num:0	801			387	507	ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; nalidixic acid; norfloxacin; sparfloxacin
BGC0001206.1|Indolmycin_12 # 11277 # 11720 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.667	BGC0001206.1|Indolmycin_12 	11277	11720	-	Loose	500	26.1794	CARB-54	32.43	3005588	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	GTGGACCGGGGCAAGCCGGGCTCCAAGATGCACGTCCTGTCGGACGCGAACGGACTGCCCCTGGTCGTCGGCGTCTCGGCCGCCAACACCCACGACAGCCAAGCCCTGAAGCCCATGGTGCTCGGTCACCAAACGAGACACGACCCCCAACGCGGCCGCCACTTCAAGCCCCAGCGCCTGCACGCCGACAAGGCCTACGACATCCCTGAACTGCGGAAATGGCTCCGCGGGAAACGCATCGGCGTCCGCATCGCCCGCAAGGGCATCGAGTCGTCAGAACGCCTCGGACGCCGTCGTTGGGTGATCGAGCGGACCATGTCCTGGCTCACCGGCTACCGCCGGCTCAACCACCGCTACGAACGACACCCCCGCAACTACCTGGCCTTCCTCGGACTGGCCGCCGCCATCTGCTGCTACAAGCGACTCCTCCGCCTCACCACATAG	VDRGKPGSKMHVLSDANGLPLVVGVSAANTHDSQALKPMVLGHQTRHDPQRGRHFKPQRLHADKAYDIPELRKWLRGKRIGVRIARKGIESSERLGRRRWVIERTMSWLTGYRRLNHRYERHPRNYLAFLGLAAAICCYKRLLRLTT	MNVRQHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAAHDLETGKRWEHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGMSLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWEPELNEAVPGDKRDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGAGGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKTVLMENSRN	49.33	gnl|BL_ORD_ID|3369|hsp_num:0	4438			579	690	
